| Revision as of 02:19, 24 September 2017 editAlyInWikiWonderland (talk | contribs)Autopatrolled, Extended confirmed users83,208 edits →List of marketed agents← Previous edit | Revision as of 02:20, 24 September 2017 edit undoAlyInWikiWonderland (talk | contribs)Autopatrolled, Extended confirmed users83,208 editsNo edit summaryNext edit → | ||
| Line 8: | Line 8: | ||
| Regular use of decongestants for long periods should be avoided because mucosal ciliary function is impaired: atrophic rhinitis and ] can occur due to persistent vasoconstriction. | Regular use of decongestants for long periods should be avoided because mucosal ciliary function is impaired: atrophic rhinitis and ] can occur due to persistent vasoconstriction. | ||
| Decongestants can be absorbed from the nose via an ] and produce systemic effects, mainly ] stimulation and rise in ]. These drugs should be used cautiously in hypertensives and in those receiving ]s (MAOIs). | Decongestants can be absorbed from the nose via an ] and produce systemic effects, mainly ] stimulation and rise in ]. These drugs should be used cautiously in hypertensives and in those receiving ]s (MAOIs), as they can cause ]. | ||
| ]s such as ] are a related type of drug which help to clear ]. | ]s such as ] are a related type of drug which help to clear ]. | ||
Revision as of 02:20, 24 September 2017
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Decongestant" – news · newspapers · books · scholar · JSTOR (July 2009) (Learn how and when to remove this message) |
A decongestant, or nasal decongestant, is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine (the latter of which has disputed efficacy).
Topical decongestants on topical application as dilute solution (0.05–0.1%) produce local vasoconstriction.
Regular use of decongestants for long periods should be avoided because mucosal ciliary function is impaired: atrophic rhinitis and anosmia can occur due to persistent vasoconstriction.
Decongestants can be absorbed from the nose via an inhaler and produce systemic effects, mainly central nervous system stimulation and rise in blood pressure. These drugs should be used cautiously in hypertensives and in those receiving monoamine oxidase inhibitors (MAOIs), as they can cause hypertensive crisis.
Expectorants such as guaifenesin are a related type of drug which help to clear mucus.
Pharmacology
The vast majority of decongestants act via enhancing norepinephrine (noradrenaline) and epinephrine (adrenaline) or adrenergic activity by stimulating the α-adrenergic receptors. This induces vasoconstriction of the blood vessels in the nose, throat, and paranasal sinuses, which results in reduced inflammation (swelling) and mucus formation in these areas.
Decongestant nasal sprays and eye drops often contain oxymetazoline and are used for topical decongestion. Pseudoephedrine acts indirectly on the adrenergic receptor system, whereas phenylephrine and oxymetazoline are direct agonists. The effects are not limited to the nose, and these medicines may cause hypertension (high blood pressure) through vasoconstriction; it is for this reason that people with hypertension are advised to avoid them. Most decongestants, however, are not pronounced stimulants, due to lack of response from the other adrenoreceptors. Besides hypertension, common side-effects include sleeplessness, anxiety, dizziness, excitability, and nervousness.
Topical nasal or ophthalmic decongestants quickly develop tachyphylaxis (a rapid decrease in the response to a drug after repeated doses over a short period of time). Long-term use is not recommended, since these agents lose effectiveness after a few days.
List of agents
Adrenaline releasing agents
Main article: Norepinephrine releasing agentCommon or widely marketed
- Ephedrine – controlled in some jurisdictions for over-the-counter use
- Levomethamphetamine (levmetamfetamine) (Vicks VapoInhaler)
- Phenylpropanolamine
- Propylhexedrine (Benzedrex)
- Pseudoephedrine (Sudafed) – controlled in some jurisdictions for over-the-counter use
- Pseudoephedrine/loratadine (Claritin-D) – also an antihistamine via loratadine
Uncommon or discontinued
α-Adrenergic receptor agonists
Main article: α-Adrenergic receptor agonistCommon or widely marketed
Uncommon or discontinued
- Corbadrine (levonordefrin)
- Epinephrine (adrenaline)
- Fenoxazoline
- Metizoline
- Norepinephrine (noradrenaline)
- Tymazoline
Miscellaneous
Common or widely marketed
Uncommon or discontinued
See also
References
| Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
|---|---|
| gastrointestinal tract / metabolism (A) | |
| blood and blood forming organs (B) | |
| cardiovascular system (C) | |
| skin (D) | |
| genitourinary system (G) | |
| endocrine system (H) | |
| infections and infestations (J, P, QI) | |
| malignant disease (L01–L02) | |
| immune disease (L03–L04) | |
| muscles, bones, and joints (M) | |
| brain and nervous system (N) |
|
| respiratory system (R) | |
| sensory organs (S) | |
| other ATC (V) | |
| Decongestants and other nasal preparations (R01) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||||
| Systemic use: Sympathomimetics | |||||||||||
| |||||||||||